|
CBFB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.35509977975346E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97289999682005E-08 |
| Normal-vs-Stage2 |
1.262700E-03 |
| Normal-vs-Stage3 |
2.26700000000024E-05 |
| Normal-vs-Stage4 |
9.315800E-03 |
| Stage1-vs-Stage2 |
5.858600E-01 |
| Stage1-vs-Stage3 |
2.177400E-01 |
| Stage1-vs-Stage4 |
5.321200E-01 |
| Stage2-vs-Stage3 |
6.700800E-01 |
| Stage2-vs-Stage4 |
8.576600E-01 |
| Stage3-vs-Stage4 |
8.719400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11109996151038E-09 |
| Normal-vs-AfricanAmerican |
6.60939999952426E-07 |
| Normal-vs-Asian |
2.611300E-04 |
| Caucasian-vs-AfricanAmerican |
7.992400E-01 |
| Caucasian-vs-Asian |
6.468400E-01 |
| AfricanAmerican-vs-Asian |
5.338400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.33900001986609E-09 |
| Normal-vs-Female |
8.43449998733092E-09 |
| Male-vs-Female |
1.050030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.982900E-04 |
| Normal-vs-Extreme_Weight |
1.07370000002049E-07 |
| Normal-vs-Obese |
1.18310000019051E-07 |
| Normal-vs-Extreme_Obese |
5.732400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.832600E-01 |
| Normal_Weight-vs-Obese |
1.224590E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.258000E-01 |
| Extreme_Weight-vs-Obese |
4.978400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.173400E-01 |
| Obese-vs-Extreme_Obese |
1.446190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02080000008442E-07 |
| Normal-vs-Age(41-60Yrs) |
3.31540350728687E-11 |
| Normal-vs-Age(61-80Yrs) |
6.0723999995016E-07 |
| Normal-vs-Age(81-100Yrs) |
1.711810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.958000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.780500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.042200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.842900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.658290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.721760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.32499583421964E-11 |
| Normal-VS-Type2 PRCC |
3.689700E-02 |
| Normal-VS-KIRP CIMP |
2.56370480400392E-11 |
| Normal-VS-Unclassified PRCC |
1.68058999999721E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.53799999957904E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.581000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.758000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.57309995322208E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.876900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.638800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.076520E-03 |
| Normal-vs-N1 |
1.64680000003248E-06 |
| Normal-vs-N2 |
2.169600E-02 |
| N0-vs-N1 |
6.387300E-04 |
| N0-vs-N2 |
6.697000E-01 |
| N1-vs-N2 |
1.890250E-02 |
|
|
